According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:
1. Centene (NYSE:CNC)
Centene (NYSE:CNC) is the #1 top healthcare plan stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year.
Learn more.
The Component Grade breakdown for Centene (NYSE:CNC) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: B.
Centene (NYSE:CNC) has a Due Diligence Score of 17, which is -18 points lower than the healthcare plan industry average of 35. Although this number is below the industry average, our proven quant model rates CNC as a "A".
CNC passed 5 out of 33 due diligence checks and has weak fundamentals. Centene has seen its stock return 154.66% over the past year, overperforming other healthcare plan stocks by 115 percentage points.
Centene has an average 1 year
price target of $67.63, an upside of 0.95% from Centene's current stock price of $66.99.
Centene stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Centene, 31.25% have issued a Strong Buy rating, 12.5% have issued a Buy, 56.25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Oscar Health (NYSE:OSCR)
Oscar Health (NYSE:OSCR) is the #2 top healthcare plan stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year.
Learn more.
The Component Grade breakdown for Oscar Health (NYSE:OSCR) is: Value: C, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.
Oscar Health (NYSE:OSCR) has a Due Diligence Score of 29, which is -6 points lower than the healthcare plan industry average of 35. Although this number is below the industry average, our proven quant model rates OSCR as a "A".
OSCR passed 10 out of 33 due diligence checks and has average fundamentals. Oscar Health has seen its stock return 85.08% over the past year, overperforming other healthcare plan stocks by 46 percentage points.
Oscar Health has an average 1 year
price target of $22.50, a downside of -25.27% from Oscar Health's current stock price of $30.11.
Oscar Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Oscar Health, 25% have issued a Strong Buy rating, 0% have issued a Buy, 75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Clover Health Investments (NASDAQ:CLOV)
The Component Grade breakdown for Clover Health Investments (NASDAQ:CLOV) is: Value: C, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.
Clover Health Investments (NASDAQ:CLOV) has a Due Diligence Score of 32, which is -3 points lower than the healthcare plan industry average of 35. Although this number is below the industry average, our proven quant model rates CLOV as a "A".
CLOV passed 11 out of 33 due diligence checks and has average fundamentals. Clover Health Investments has seen its stock return 106.19% over the past year, overperforming other healthcare plan stocks by 67 percentage points.
Clover Health Investments has an average 1 year
price target of $4.25, an upside of 2.66% from Clover Health Investments's current stock price of $4.14.
Clover Health Investments stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Clover Health Investments, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.